node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
A0A1L8EYG2 | Egf.L | A0A1L8EYG2 | A0A1L8HUT3 | ENTH domain-containing protein. | Uncharacterized protein. | 0.566 |
A0A1L8EYG2 | Tfap2a.L | A0A1L8EYG2 | A0A1L8FXY3 | ENTH domain-containing protein. | TF_AP-2 domain-containing protein. | 0.742 |
A0A1L8EYG2 | egfr | A0A1L8EYG2 | A0A1L8FRS8 | ENTH domain-containing protein. | Receptor protein-tyrosine kinase. | 0.829 |
A0A1L8EYG2 | egfr-2 | A0A1L8EYG2 | A0A1L8FWP8 | ENTH domain-containing protein. | Receptor protein-tyrosine kinase. | 0.829 |
A0A1L8EYG2 | erbb2 | A0A1L8EYG2 | A0A1L8ES20 | ENTH domain-containing protein. | Receptor protein-tyrosine kinase. | 0.484 |
A0A1L8EYG2 | grb2 | A0A1L8EYG2 | A0A1L8EMZ6 | ENTH domain-containing protein. | Uncharacterized protein. | 0.637 |
A0A1L8EYG2 | grb2-2 | A0A1L8EYG2 | A0A1L8EUF2 | ENTH domain-containing protein. | Uncharacterized protein. | 0.637 |
A0A1L8EYG2 | tfap2a | A0A1L8EYG2 | A0A1L8FS35 | ENTH domain-containing protein. | TF_AP-2 domain-containing protein. | 0.741 |
A0A1L8FND1 | Egf.L | A0A1L8FND1 | A0A1L8HUT3 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Uncharacterized protein. | 0.962 |
A0A1L8FND1 | Slc2a4.L | A0A1L8FND1 | A0A1L8H4N2 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | MFS domain-containing protein; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.924 |
A0A1L8FND1 | egfr | A0A1L8FND1 | A0A1L8FRS8 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Receptor protein-tyrosine kinase. | 0.876 |
A0A1L8FND1 | egfr-2 | A0A1L8FND1 | A0A1L8FWP8 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Receptor protein-tyrosine kinase. | 0.876 |
A0A1L8FND1 | erbb2 | A0A1L8FND1 | A0A1L8ES20 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Receptor protein-tyrosine kinase. | 0.795 |
A0A1L8FND1 | grb2 | A0A1L8FND1 | A0A1L8EMZ6 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Uncharacterized protein. | 0.722 |
A0A1L8FND1 | grb2-2 | A0A1L8FND1 | A0A1L8EUF2 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Uncharacterized protein. | 0.722 |
A0A1L8FND1 | ins | A0A1L8FND1 | A0A1L8GD41 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.907 |
A0A1L8FND1 | ins-2 | A0A1L8FND1 | B7ZQP1 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.905 |
A0A1L8FND1 | tgfb1 | A0A1L8FND1 | A0A1L8F3Y7 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Transforming growth factor beta; Belongs to the TGF-beta family. | 0.683 |
A0A1L8FND1 | tgfb1-2 | A0A1L8FND1 | A0A1L8F936 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Transforming growth factor beta; Belongs to the TGF-beta family. | 0.683 |
Egf.L | A0A1L8EYG2 | A0A1L8HUT3 | A0A1L8EYG2 | Uncharacterized protein. | ENTH domain-containing protein. | 0.566 |